Vestmark Advisory Solutions, Inc.

SEC CIK: 0001736982
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

VRTX holding history

Vertex Pharmaceuticals Inc in every 13F filed by Vestmark Advisory Solutions, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VRTX overview All 13F holders of VRTX Full Q2 2026 holdings

Shares (Q2 2026): 7,762
Value: $3.86M
% of portfolio: <0.1%
Quarters held: 22; Since Q1 2021

Holdings of VRTX by Vestmark Advisory Solutions, Inc., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	7,762	$3.86M	<0.1%	+805+11.6%	Added	Holders
Q1 2026	6,957	$3.11M	<0.1%	−865−11.1%	Reduced	Holders
Q4 2025	7,822	$3.55M	<0.1%	−1,606−17.0%	Reduced	Holders
Q3 2025	9,428	$3.69M	0.1%	+665+7.6%	Added	Holders
Q2 2025	8,763	$3.90M	0.1%	−3,625−29.3%	Reduced	Holders
Q1 2025	12,388	$6.01M	0.2%	+6,595+113.8%	Added	Holders
Q4 2024	5,793	$2.33M	0.1%	−346−5.6%	Reduced	Holders
Q3 2024	6,139	$2.86M	0.1%	+26+0.4%	Added	Holders
Q2 2024	6,113	$2.87M	0.1%	+4,610+306.7%	Added	Holders
Q1 2024	1,503	$628.3K	<0.1%	−2−0.1%	Reduced	Holders
Q4 2023	1,505	$612.4K	<0.1%	−164−9.8%	Reduced	Holders
Q3 2023	1,669	$580.4K	<0.1%	−15,332−90.2%	Reduced	Holders
Q2 2023	17,001	$5.98M	0.2%	−219−1.3%	Reduced	Holders
Q1 2023	17,220	$5.43M	0.2%	−734−4.1%	Reduced	Holders
Q4 2022	17,954	$5.18M	0.3%	−204−1.1%	Reduced	Holders
Q3 2022	18,158	$5.26M	0.3%	−591−3.2%	Reduced	Holders
Q2 2022	18,749	$5.28M	0.3%	−1,024−5.2%	Reduced	Holders
Q1 2022	19,773	$5.16M	0.3%	−209−1.0%	Reduced	Holders
Q4 2021	19,982	$4.39M	0.2%	−357−1.8%	Reduced	Holders
Q3 2021	20,339	$3.69M	0.2%	−400−1.9%	Reduced	Holders
Q2 2021	20,739	$4.18M	0.3%	+1,197+6.1%	Added	Holders
Q1 2021	19,542	$4.20M	0.4%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.